News

An Aetna subsidiary is the lead defendant, but Aetna says the subsidiary should not be part of the case.

An association that includes the umpires says that they could help by explaining their calls more clearly.

The drugmaker is the third to sue over new restrictions that carry penalties of up to $1,000 for each affected drug transaction.

Patients and providers argue that it can result in delays or denials in receiving needed care, while insurers counter that it helps reduce costs by limiting the use of low-value or unnecessary care.

"Many workers are not just worried about retirement. They are actively revising their timelines," said Jasmine Escalera, career expert at MyPerfectResume.

The ruling addresses the standards employer plans must meet to win a prescription drug market antitrust suit.